Literature DB >> 21906664

Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.

Mikhail S Shchepinov1, Vivian P Chou, Erik Pollock, J William Langston, Charles R Cantor, Robert J Molinari, Amy B Manning-Boğ.   

Abstract

Oxidative damage of membrane polyunsaturated fatty acids (PUFA) is thought to play a major role in mitochondrial dysfunction related to Parkinson's disease (PD). The toxic products formed by PUFA oxidation inflict further damage on cellular components and contribute to neuronal degeneration. Here, we tested the hypothesis that isotopic reinforcement, by deuteration of the bisallylic sites most susceptible to oxidation in PUFA may provide at least partial protection against nigrostriatal injury in a mouse model of oxidative stress and cell death, the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model. Mice were fed a fat-free diet supplemented with saturated acids, oleic acid and essential PUFA: either normal, hydrogenated linoleic (LA, 18:2n-6) and α-linolenic (ALA, 18:3n-3) or deuterated 11,11-D2-LA and 11,11,14,14-D4-ALA in a ratio of 1:1 (to a total of 10% mass fat) for 6 days; each group was divided into two cohorts receiving either MPTP or saline and then continued on respective diets for 6 days. Brain homogenates from mice receiving deuterated PUFA (D-PUFA) vs. hydrogenated PUFA (H-PUFA) demonstrated a significant incorporation of deuterium as measured by isotope ratio mass-spectrometry. Following MPTP exposure, mice fed H-PUFA revealed 78.7% striatal dopamine (DA) depletion compared to a 46.8% reduction in the D-PUFA cohort (as compared to their respective saline-treated controls), indicating a significant improvement in DA concentration with D-PUFA. Similarly, higher levels of the DA metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) were detected in MPTP-exposure mice administered D-PUFA; however, saline-treated mice revealed no change in DA or DOPAC levels. Western blot analyses of tyrosine hydroxylase (TH) confirmed neuroprotection with D-PUFA, as striatal homogenates showed higher levels of TH immunoreactivity in D-PUFA (88.5% control) vs. H-PUFA (50.4% control) in the MPTP-treated cohorts. In the substantia nigra, a significant improvement was noted in the number of nigral dopaminergic neurons following MPTP exposure in the D-PUFA (79.5% control) vs. H-PUFA (58.8% control) mice using unbiased stereological cell counting. Taken together, these findings indicate that dietary isotopic reinforcement with D-PUFA partially protects against nigrostriatal damage from oxidative injury elicited by MPTP in mice. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21906664     DOI: 10.1016/j.toxlet.2011.07.020

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  24 in total

1.  Unusual kinetic isotope effects of deuterium reinforced polyunsaturated fatty acids in tocopherol-mediated free radical chain oxidations.

Authors:  Connor R Lamberson; Libin Xu; Hubert Muchalski; J Rafael Montenegro-Burke; Vadim V Shmanai; Andrei V Bekish; John A McLean; Catherine F Clarke; Mikhail S Shchepinov; Ned A Porter
Journal:  J Am Chem Soc       Date:  2014-01-08       Impact factor: 15.419

2.  Dietary fat intake, pesticide use, and Parkinson's disease.

Authors:  Freya Kamel; Samuel M Goldman; David M Umbach; Honglei Chen; Gina Richardson; Marie Richards Barber; Cheryl Meng; Connie Marras; Monica Korell; Meike Kasten; Jane A Hoppin; Kathleen Comyns; Anabel Chade; Aaron Blair; Grace S Bhudhikanok; G Webster Ross; J William Langston; Dale P Sandler; Caroline M Tanner
Journal:  Parkinsonism Relat Disord       Date:  2013-10-01       Impact factor: 4.891

3.  Dietary fat intake and risk for Parkinson's disease.

Authors:  Jing Dong; John D Beard; David M Umbach; YikYung Park; Xuemei Huang; Aaron Blair; Freya Kamel; Honglei Chen
Journal:  Mov Disord       Date:  2014-09-03       Impact factor: 10.338

4.  Deuterated polyunsaturated fatty acids reduce brain lipid peroxidation and hippocampal amyloid β-peptide levels, without discernable behavioral effects in an APP/PS1 mutant transgenic mouse model of Alzheimer's disease.

Authors:  Sophia M Raefsky; Ran Furman; Ginger Milne; Erik Pollock; Paul Axelsen; Mark P Mattson; Mikhail S Shchepinov
Journal:  Neurobiol Aging       Date:  2018-03-05       Impact factor: 4.673

5.  Small amounts of isotope-reinforced polyunsaturated fatty acids suppress lipid autoxidation.

Authors:  Shauna Hill; Connor R Lamberson; Libin Xu; Randy To; Hui S Tsui; Vadim V Shmanai; Andrei V Bekish; Agape M Awad; Beth N Marbois; Charles R Cantor; Ned A Porter; Catherine F Clarke; Mikhail S Shchepinov
Journal:  Free Radic Biol Med       Date:  2012-06-15       Impact factor: 7.376

6.  Competition H(D) kinetic isotope effects in the autoxidation of hydrocarbons.

Authors:  Hubert Muchalski; Alexander J Levonyak; Libin Xu; Keith U Ingold; Ned A Porter
Journal:  J Am Chem Soc       Date:  2014-12-31       Impact factor: 15.419

Review 7.  Oxidative and nitrative stress in neurodegeneration.

Authors:  Catherine A Cobb; Marsha P Cole
Journal:  Neurobiol Dis       Date:  2015-05-27       Impact factor: 5.996

Review 8.  HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.

Authors:  Eugenio Barone; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  Free Radic Biol Med       Date:  2016-11-10       Impact factor: 7.376

9.  Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis.

Authors:  Wan Seok Yang; Katherine J Kim; Michael M Gaschler; Milesh Patel; Mikhail S Shchepinov; Brent R Stockwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-09       Impact factor: 11.205

10.  Deuterium-reinforced polyunsaturated fatty acids improve cognition in a mouse model of sporadic Alzheimer's disease.

Authors:  Ahmed Elharram; Nicole M Czegledy; Michael Golod; Ginger L Milne; Erik Pollock; Brian M Bennett; Mikhail S Shchepinov
Journal:  FEBS J       Date:  2017-10-27       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.